EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Acuren Corporation (TIC) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Acuren Corporation $4.45, price $8.93, upside -50.2%, quality 28 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Industrials · US · ISIN US00510N1028

AC Acuren Corporation logo Some data Sep 24, 2026

Acuren Corporation

TIC · US

Weakest SetupStrongly overvalued and low quality.

!Fair value $4.45 · Strongly overvalued (−50%)
!Quality 28/100
!Mixed Growth (revenue 3y +18.1 %/yr)
!Loss-making · -5.8% net margin (TTM)
✓Moderate debt · generates free cash flow
!Trails peers (2/12)
!Narrow moat 20/100
!Evidence only medium, so the estimate is less certain
!The models disagree: range $1.38 to $9.34

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$14.49 $6.54 Fair Value $4.45 Feb 2025 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

19‑month range $6.54 – $14.49 · fair‑value band $1.38 – $9.34 · the $8.93 price screens above the $4.45 fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow Acuren in your weekly email

Every Wednesday you see whether Acuren is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

TIC Solutions, Inc. provides critical asset integrity services in North America. The company offers testing, inspection, certification, and compliance (TICC) services, including various nondestructive testing (NDT) techniques, such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection.

Show more

TIC Solutions, Inc. provides critical asset integrity services in North America. The company offers testing, inspection, certification, and compliance (TICC) services, including various nondestructive testing (NDT) techniques, such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection. Its NDT activities include inspection and evaluation of industrial equipment through various technology-enabled methods to ensure asset integrity, prevent costly outages, failures, and accidents, and meet regulatory requirements without damaging the asset or component. It also provides market rope access technician solutions, including inspection and testing, as well as insulation, coatings and blasting, welding, pipe fitting, hoisting and rigging, and electrical services. In addition, its TICC services include support from consulting engineers with destructive testing, support failure investigation, material selection, corrosion engineering, welding engineering, fracture mechanics, destructive testing, and chemical analysis. Further, it offers geospatial services, such as data collection, data analytics, and software solutions that support asset management and infrastructure planning. The company serves a range of industrial markets, such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. TIC Solutions, Inc. was formerly known as Acuren Corporation and changed its name to TIC Solutions, Inc. in October 2025. The company was founded in 1974 and is headquartered in Hollywood, Florida.

Stock analysis

Acuren Corporation (TIC) currently trades at $8.93, while our model-based Fair Value estimate is $4.45, implying the stock looks roughly 100.8% overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $9.56 per share, and 3 of the 8 models we run sit above the $8.93 price.

Bear case: the Multiples group reads lowest at $5.80, and 5 of the 8 models stay below the price. Evidence for this calculation is medium.

Scenario range: $1.38 (bear) to $9.34 (bull), the price of $8.93 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 28/100 (below-average quality), in the Industrials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Acuren Corporation reported revenue of $1.5B in FY2025 versus $928M in FY2022, a compound +18.1%/yr. Reported net income was −$87.1M in FY2025.

Key figures

Market cap $1.8B · P/S ratio 1.00 · EPS (TTM) $−0.5800 · Net margin −5.7% · Return on equity −6.3% · Return on assets (EBIT) 1.3% · Operating margin −0.9% · Revenue (TTM) $1.8B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).

What moves the price

The share trades about 38% below its 52-week high and 37% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at 0% fair-value upside, at −50%, TIC screens richer than that median.

Fair Value models

Bear $1.38 Fair Value $4.45 Bull $9.34
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Growth DCF $2.42 $8.22 $18.03 68
FCF DCF $2.81 $7.40 $19.26 67
Rev-Margin DCF n/a n/a $0.5500 66
All 9 models by family
DCF Models
FCF DCF $2.81 $7.40 $19.26 67
Owner Earnings $2.60 $10.79 $25.86 64
5Y EBITDA Exit $2.73 $9.56 $21.47 64
10Y Revenue Exit n/a $1.31 $2.91 61
10Y EBITDA Exit $2.65 $9.88 $22.69 58
Multiples
EV/EBITDA $3.05 $5.80 $8.54 64
Asset-Based
NCAV (Graham) $4.93 $6.61 $9.86 54
Growth DCF
Growth DCF $2.42 $8.22 $18.03 68
Rev-Margin DCF n/a n/a $0.5500 66

Open the full fair value analysis →

Notify me when TIC reaches fair value

Put TIC on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 28/100

Of which business quality 30 · Market factors (momentum, volatility) 26

Profitability 10
Margins and returns on capital today
Quality Growth 73
Are margins and returns improving?
Cashflow 37
Earnings quality: real cash, not paper profit
Fin. Strength 34
Balance sheet, leverage, solvency risk
Investment 33
Disciplined investing over empire-building
Low Volatility 10
Calm price path (market factor)
Momentum 42
Price trend over the last 3–12 months (market factor)
52W Momentum 15
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+39.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
3.7% (2022) → 0.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+33.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+10.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +30.1% a year for the price and +8.3% for the forecasts.
Forecast 2026 (sales)+43.4%
Forecast 2027 (sales)+4.4%
Projected 2028 (sales)+4.1%
Projected 2029 (sales)+3.8%
Projected 2030 (sales)+3.5%

TIC screens 101% overvalued. Compare with Cintas Corporation →

Compare Acuren Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 248 stocks

Beats the industry median on 1/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 28 · Bottom 25%
Fair Value upside −50% · Bottom 25%
Profitability
Return on assets 0% · Bottom 25%
Net margin (TTM) −6% · Bottom 25%
Operating margin (TTM) −1% · Bottom 25%
Growth and dividend
Revenue growth 108% · Top 25%
Balance sheet
Debt / equity 0.73× · Highest 25%

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/B 0.82× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM) 1.00× · Pricier than median
P/FCF 29.1× · Priciest 25%
EV/EBITDA 13.2× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 43
FUTURE (revenue growth)100 · sector 27
PAST (return on equity)0 · sector 36
HEALTH (low debt)64 · sector 90
DIVIDEND (yield)0 · sector 53

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Cintas Corporation CTAS $198.80 $181.30 −9%
Thomson Reuters Corporation TRI $95.66 $70.26 −27%
Copart, Inc CPRT $28.80 $32.23 +12%
Global Payments Inc GPN $84.78 $85.85 +1%
RB Global, Inc RBA C$117.34 C$129.07 +10%
UL Solutions Inc ULS $66.65 $33.62 −50%
Brambles Limited BXB A$18.73 A$18.66 +0%
Wolters Kluwer N.V WKL €66.82 €97.78 +46%
Aramark ARMK $56.59 $23.15 −59%
Rentokil Initial plc RTO $21.37 $19.63 −8%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Acuren Corporation Fair Value". https://www.fairvalue-calculator.com/stock/TIC

Frequently asked questions

Is Acuren Corporation (TIC) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $4.45 versus a price of $8.93, about −50% upside (overvalued).
What is the fair value of TIC?
Our model-based fair value for Acuren Corporation is $4.45 (as of Sep 24, 2026), built from audited fundamentals. The current price: $8.93.
What is the quality score of TIC?
Acuren Corporation has a Quality Score of 28/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Acuren Corporation (TIC)?
Our model-based price target is the fair value of $4.45 (as of Sep 24, 2026) from 9 valuation models. Cautious scenario $1.38, optimistic scenario $9.34. It is a calculation from audited fundamentals, not an analyst target.
What is the Acuren Corporation stock forecast for 2026?
Our models put fair value at $4.45, about −50% upside versus a price of $8.93 (overvalued). Cautious scenario $1.38, optimistic scenario $9.34. The calculation is refreshed regularly with new filings.
What is the revenue of Acuren Corporation (TIC)?
Acuren Corporation reported trailing-twelve-month revenue of about $1.8B (latest available figure, as of Sep 24, 2026).
What growth is priced into Acuren Corporation (TIC)?
For today's price to be fair in a discounted-cash-flow model, Acuren Corporation would have to grow free cash flow by +33.2 % per year for five years (discount rate 13.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 3 years revenue grew +18.1 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of TIC use?
Our models discount Acuren Corporation at 13.3 %: a base by market capitalisation (small), damped by beta 1.74, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Acuren Corporation that is +33.2 % per year a year over ten years, using the same discount rate (13.3 %) and the same formula as our fair value.
How much growth has Acuren Corporation (TIC) delivered so far?
Over the past 3 years revenue at Acuren Corporation grew +18.1 % a year. The price currently implies +33.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Acuren Corporation (TIC) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Acuren Corporation (+33.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Acuren Corporation (TIC)?
The free-cash-flow yield on the price is 4.35 %: that much free cash flow Acuren Corporation produces per unit of market value. When it exceeds the discount rate of our models (13.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Acuren Corporation (TIC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Acuren Corporation it is $4.45 per share (as of Sep 24, 2026), against a price of $8.93. It is the blended result of 9 valuation models (cash flow, earnings, asset, dividend).
Is Acuren Corporation stock overvalued or undervalued in 2026?
As of Sep 24, 2026, TIC trades above its calculated fair value: price $8.93, fair value $4.45, a gap of about −50% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TIC?
No. The price is what the market pays today ($8.93); the fair value is what the company's own numbers justify ($4.45). For Acuren Corporation the two are $4.48 per share apart. That gap is exactly why we show both numbers side by side.
How much is Acuren Corporation worth?
The market values Acuren Corporation at about $1.8B (market capitalisation, as of Sep 24, 2026). Per share that is $8.93; our models calculate a fair value of $4.45 per share.
What do the bullish and bearish scenarios say about TIC?
Our models span a range for Acuren Corporation: cautious scenario $1.38, base $4.45, optimistic $9.34 per share (as of Sep 24, 2026, price $8.93). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Acuren Corporation (TIC)?
Balance-sheet figures for Acuren Corporation (as of Sep 24, 2026): return on equity −6.3%, debt of 0.73 per unit of equity. They feed the Quality Score of 28/100, which measures business quality independently of the share price.
How far is TIC from its 52-week high?
Acuren Corporation trades at $8.93, about 38% below its 52-week high of $14.49 and 37% above the low of $6.54 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $4.45 is for.
Which stocks are comparable to Acuren Corporation?
From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Acuren Corporation stock attractive at the current price?
The data as of Sep 24, 2026: price $8.93, calculated fair value $4.45 (−50%), Quality Score 28/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TIC calculated?
We run Acuren Corporation through 9 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $4.45, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Acuren Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Acuren Corporation (TIC)?
The closing price on Sep 23, 2026 was $8.93. Our model-based fair value is $4.45, about −50% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Acuren Corporation right now?
Weak quality (28/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide ($1.38 to $9.34). The outcome hinges heavily on assumptions, so read the point estimate with caution.

Key figures of Acuren Corporation

How large is the market capitalisation of Acuren Corporation (TIC)?
The market capitalisation of Acuren Corporation is $1.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Acuren Corporation (TIC)?
The price-to-sales ratio of Acuren Corporation is 1.00 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Acuren Corporation (TIC)?
Earnings per share at Acuren Corporation are $−0.5800. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Acuren Corporation (TIC)?
The net margin of Acuren Corporation is −5.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Acuren Corporation (TIC)?
The return on equity (ROE) of Acuren Corporation is −6.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Acuren Corporation (TIC)?
On an EBIT basis the return on assets of Acuren Corporation is 1.3% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Acuren Corporation (TIC)?
The operating margin of Acuren Corporation is −0.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Acuren Corporation (TIC)?
Revenue at Acuren Corporation is growing +108% versus a year earlier (3y avg +18.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Acuren Corporation (TIC) carry?
The net debt of Acuren Corporation is $1.3B (fiscal year 2025, ≈ 20.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Acuren Corporation in the live analysis

One click puts Acuren Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.